164 related articles for article (PubMed ID: 32722374)
1. Increased One-Year Recurrent Ischemic Stroke after First-Ever Ischemic Stroke in Males with Benign Prostatic Hyperplasia.
Cheng CG; Chu H; Lee JT; Chien WC; Cheng CA
Int J Environ Res Public Health; 2020 Jul; 17(15):. PubMed ID: 32722374
[TBL] [Abstract][Full Text] [Related]
2. Association of alpha-1-adrenergic antagonist use with the risk of gout development in benign prostatic hyperplasia patients: a population-based cohort study.
Hsu WH; Lai JN; Lin CL; Loh CH; Huang HK; Huang LK
Fam Pract; 2022 May; 39(3):426-431. PubMed ID: 34964888
[TBL] [Abstract][Full Text] [Related]
3. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
[TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism is not a significant risk of benign prostatic hyperplasia: A nationwide population-based study.
Man KM; Chen KB; Chen HY; Chiang JH; Su YC; Man SS; Xie DD; Wang Y; Zhang ZQ; Bi LK; Zhang T; Yu DX; Chen WC
Medicine (Baltimore); 2018 Sep; 97(39):e12459. PubMed ID: 30278528
[TBL] [Abstract][Full Text] [Related]
5. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.
Cindolo L; Pirozzi L; Fanizza C; Romero M; Tubaro A; Autorino R; De Nunzio C; Schips L
Eur Urol; 2015 Sep; 68(3):418-25. PubMed ID: 25465970
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan.
Sung SY; Le TTH; Chen JH; Hsieh TF; Hsieh CL
PLoS One; 2020; 15(11):e0242429. PubMed ID: 33211759
[TBL] [Abstract][Full Text] [Related]
7. The Cardiovascular Safety of Five-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study.
Ayele HT; Reynier P; Azoulay L; Platt RW; Benayoun S; Filion KB
Am J Med; 2023 Oct; 136(10):1000-1010.e7. PubMed ID: 37481022
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of benign prostate hyperplasia in sleep apnea patients: a nationwide population-based study.
Chou PS; Chang WC; Chou WP; Liu ME; Lai CL; Liu CK; Ku YC; Tsai SJ; Chou YH; Chang WP
PLoS One; 2014; 9(3):e93081. PubMed ID: 24667846
[TBL] [Abstract][Full Text] [Related]
9. Association of sleep traits with benign prostatic hyperplasia in middle-aged and elderly men: A prospective analysis in UK Biobank.
Wu Y; Wang W; Wang Y; Zhao Y; You D; Zhang W; Xia J; Gu Y; Qian Q; Hong Y; Sun G
Geriatr Gerontol Int; 2024 Jul; 24(7):675-682. PubMed ID: 38764254
[TBL] [Abstract][Full Text] [Related]
10. Associated with Ischemic Stroke Risk Reduction after Endoscopic Thoracic Sympathectomy for Palmar Sweating.
Cheng CG; Cheng CA; Chien WC; Chung CH; Lee JT
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2235-2242. PubMed ID: 29784606
[TBL] [Abstract][Full Text] [Related]
11. Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study.
Peng YH; Huang CW; Liao WC; Chen HJ; Yin MC; Huang YM; Wu TN; Ho WC
BMJ Open; 2017 Jun; 7(6):e015581. PubMed ID: 28645971
[TBL] [Abstract][Full Text] [Related]
12. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia.
Duan Y; Grady JJ; Albertsen PC; Helen Wu Z
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):340-348. PubMed ID: 29316005
[TBL] [Abstract][Full Text] [Related]
13. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
[TBL] [Abstract][Full Text] [Related]
14. Nonapnea sleep disorders are associated with subsequent ischemic stroke risk: a nationwide, population-based, retrospective cohort study.
Huang WS; Tsai CH; Lin CL; Sung FC; Chang YJ; Kao CH
Sleep Med; 2013 Dec; 14(12):1341-7. PubMed ID: 24211072
[TBL] [Abstract][Full Text] [Related]
15. An Analysis of Long-Term Ischemic Stroke Risk in Survivors of Septicemia.
Cheng CA; Cheng CG; Lee JT; Lin HC; Cheng CC; Chiu HW
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2893-2900. PubMed ID: 28802520
[TBL] [Abstract][Full Text] [Related]
16. Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.
Lin TY; Chen IH; Weng HY; Lin YC; Ou CH; Li CY; Cheng YS
World J Urol; 2024 Mar; 42(1):126. PubMed ID: 38460003
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Syndrome, Its Components, and Diabetes on 5-Year Risk of Recurrent Stroke among Mild-to-Moderate Ischemic Stroke Survivors: A Multiclinic Registry Study.
Fang X; Liu H; Zhang X; Zhang H; Qin X; Ji X
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):626-34. PubMed ID: 26725129
[TBL] [Abstract][Full Text] [Related]
18. Use of 5-alpha-reductase inhibitors did not increase the risk of cardiovascular diseases in patients with benign prostate hyperplasia: a five-year follow-up study.
Hsieh TF; Yang YW; Lee SS; Lin TH; Liu HH; Tsai TH; Chen CC; Huang YS; Lee CC
PLoS One; 2015; 10(3):e0119694. PubMed ID: 25803433
[TBL] [Abstract][Full Text] [Related]
19. Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality.
Van Rompay MI; Curtis Nickel J; Ranganathan G; Kantoff PW; Solomon KR; Lund JL; McKinlay JB
BJU Int; 2019 Mar; 123(3):511-518. PubMed ID: 30216624
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of atrial fibrillation in patients with benign prostatic hyperplasia: A population-based cohort study.
Hu WS; Lin CL
Clin Cardiol; 2018 Oct; 41(10):1374-1378. PubMed ID: 30144121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
